Author

V. Becker

Observed institution: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

OpenAlex ID: A5000636355

Small Molecule Inhibitors Targeting Transgelin-2-Actin Interaction for Therapeutic Intervention in Glioblastoma

2022 · A. Kumar, P. Rajasekera, et al. · International Journal of Radiation Oncology*Biology*Physics · 2

Hypoxia-Inducible Transgelin-2 Confers Treatment Resistance through Activation of PI3K/Akt/GSK3β Pathway in Glioblastoma

2023 · A. Kumar, P. Rajasekera, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

Radiation-Induced HMGB2 Cytoplasmic Translocation Associates with Enhanced Immune Response Pathways in Glioma

2025 · A.P. Becker, V. Becker, et al. · International Journal of Radiation Oncology*Biology*Physics

PD-0818 TRIB1 confers resistance to radiation treatment in GBM by inhibiting p53 function

2023 · K. Singh, C. Han, et al. · Radiotherapy and Oncology

PO-1145 Targeting Transgelin-2 by novel small molecule inhibitors to circumvent resistance in glioblastoma

2023 · A. Kumar, P. Rajasekera, et al. · Radiotherapy and Oncology

Works count: 5

Citation count: 3

H-index: 1

I10-index: